Wikidata

(Q40400262)

English

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on 21 December 2016

In more languages

Statements

title
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
28002679
retrieved
20 September 2017
main subject
multiple sclerosis
0 references
ocrelizumab
0 references
author
Krzysztof Selmaj
object named as
Krzysztof Selmaj
series ordinal
10
0 references
Frauke Zipp
0 references
author name string
Gaelle Klingelschmitt
series ordinal
14
1 reference
stated in
Europe PubMed Central
PubMed ID
28002679
retrieved
20 September 2017
Paulo Fontoura
series ordinal
16
1 reference
stated in
Europe PubMed Central
PubMed ID
28002679
retrieved
20 September 2017
Peter Chin
series ordinal
18
1 reference
stated in
Europe PubMed Central
PubMed ID
28002679
retrieved
20 September 2017
OPERA I and OPERA II Clinical Investigators
series ordinal
22
1 reference
stated in
Europe PubMed Central
PubMed ID
28002679
retrieved
20 September 2017
publication date
21 December 2016
1 reference
stated in
Europe PubMed Central
PubMed ID
28002679
retrieved
20 September 2017
page(s)
221-234
1 reference
stated in
Europe PubMed Central
PubMed ID
28002679
retrieved
20 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40400262&oldid=2096621526"